Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Mitochondrial 4-hydroxyphenylpyruvate dioxygenase-like prote...

Class:IdSummation:9856721
_displayNameMitochondrial 4-hydroxyphenylpyruvate dioxygenase-like prote...
_timestamp2023-12-22 09:30:04
created[InstanceEdit:9856699] Stephan, Ralf, 2023-12-22
textMitochondrial 4-hydroxyphenylpyruvate dioxygenase-like protein (HPDL) was shown to process 4-hydroxphenylpyruvate (HPPA) to (S)-4-hydroxymandelate (4-HMA). HPDL defects lead to CoQ10 deficiency, and the HPDL product 4-hydroxymandelate apparently is a precursor for the synthesis of 4-hydroxybenzoate, which is a prerequisite for the assembly of the CoQ10 head group (Banh et al., 2021). Because HPDL is a mitochondrial protein, cytosolic HPPA from tyrosine catabolism must be imported by an unknown transport mechanism (Husain et al., 2020; reviewed in Staiano et al., 2023).
(summation)[Reaction:9856718] HPDL dioxygenates HPPA [Homo sapiens]
[Change default viewing format]
No pathways have been reviewed or authored by Mitochondrial 4-hydroxyphenylpyruvate dioxygenase-like prote... (9856721)